Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Development of a Short Version of MSQOL-54 Using Factor Analysis and Item Response Theory.
A telemedicine meditation intervention for people with multiple sclerosis and their caregivers: study protocol for a randomized controlled trial.
Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice.
Low myo-inositol indicating astrocytic damage in a case series of NMO.
FDG PET/CT in Acute Tumefactive Multiple Sclerosis Occurring in a Case of Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.
Tau protein levels in the cerebrospinal fluid of the patients with multiple sclerosis in an attack period: Low levels of tau protein may have significance, too.
Clinical Neurophysiology in multiple sclerosis - From diagnostic tool to biomarker.
Hydrogen sulfide controls peripheral nerve degeneration and regeneration: a novel therapeutic strategy for peripheral demyelinating disorders or nerve degenerative diseases.
Longitudinal PET imaging for monitoring myelin repair in the spinal cord.
A Low-Cost Cognitive Rehabilitation With a Commercial Video Game Improves Sustained Attention and Executive Functions in Multiple Sclerosis: A Pilot Study.
Multiple sclerosis incidence associated with the soil lead and arsenic concentrations in taiwan.
Assessing PML risk under immunotherapy: if all you have is a hammer, everything looks like a nail.
Acquired Immunologic Neuropathies.
New data show Novartis' Gilenya® reduced brain volume loss by one third and confirm brain volume loss link with disability in MS patients
Morphologic features of the binucleated lymphocytes for the assesment of persistent B-cell polyclonal lymphocytosis.
PDGF is Required for Remyelination-Promoting IgM Stimulation of Oligodendrocyte Progenitor Cell Proliferation.
Perceptions of Participants in a Group, Community, Exercise Programme for People with Multiple Sclerosis.
Measuring Gray Matter and White Matter Damage in MS: Why This is Not Enough.
Inducible Expression of CXCL1 within the Central Nervous System Amplifies Viral-Induced Demyelination.
Multiple sclerosis relapse phenotype is an important, neglected, determinant of disease outcome - YES.
Estrogen treatment of experimental autoimmune encephalomyelitis requires E2 receptor positive B cells that upregulate PD-1 on CD4(+) Foxp3(+) Treg cells.
Factors Influencing Decision-making and Outcome in the Surgical Management of Trigeminal Neuralgia.
Transcriptomic profile of host response in mouse brain after exposure to plant toxin abrin.
Dietary Luteolin Reduces Proinflammatory Microglia in the Brain of Senescent Mice.
[Contribution of cerebral magnetic resonance imaging to etiological investigation of uveitis.]
Pages
« first
‹ previous
…
609
610
611
612
613
614
615
616
617
…
next ›
last »